Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | GPR3 | P46089 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | KIF11 | P52732 | 2/20 | 0.40 |
| ▸ | NOS3 | P29474 | 2/20 | 0.40 |
| ▸ | NOS1 | P29475 | 2/20 | 0.40 |
| ▸ | NOS2 | P35228 | 2/20 | 0.40 |
| ▸ | PDE2A | O00408 | 1/20 | 0.39 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL254957 | 0.84 | MAPT (0.56) | EPHX2MAPTGPR3L3MBTL1KDM4E | |
| SCHEMBL5043580 | 0.81 | MAPT (0.42) | EPHX2MAPTGPR3L3MBTL1KDM4E | |
| SCHEMBL17791002 | 0.81 | MAPT (0.47) | EPHX2MAPTGPR3L3MBTL1KDM4E | |
| SCHEMBL514679 | 0.81 | MAPT (0.42) | EPHX2MAPTGPR3L3MBTL1KDM4E | |
| SCHEMBL514680 | 0.81 | CYP1A1 (0.44) | EPHX2MAPTGPR3L3MBTL1KDM4E | |
| SCHEMBL4116218 | 0.81 | MAPT (0.42) | EPHX2MAPTGPR3L3MBTL1KDM4E | |
| SCHEMBL2949216 | 0.81 | MAPT (0.42) | EPHX2MAPTGPR3L3MBTL1KDM4E | |
| SCHEMBL13923555 | 0.78 | PDE2A (0.42) | EPHX2MAPTGPR3L3MBTL1KIF11 | |
| SCHEMBL7940692 | 0.78 | CHRNA7 (0.52) | EPHX2MAPTGPR3L3MBTL1ALDH1A1 | |
| SCHEMBL7955721 | 0.78 | MAPT (0.40) | EPHX2MAPTGPR3L3MBTL1KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119390626-A | NHC-BH3Method for synthesizing disulfide derivative based on sulfonyl hydrazine under catalysis | 湖南大学 | 2025-02-07 | — | — | CN | disclosed |
| US-8987516-B2 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES, LTD. (JP) | 2015-03-24 | — | — | US | disclosed |
| EP-2468722-B1 | Process for producing arylsulfur halotetrafluorides | UBE INDUSTRIES (JP) | 2014-10-01 | — | — | EP | disclosed |
| EP-2468721-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2014-02-26 | — | — | EP | disclosed |
| EP-2468720-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2013-11-27 | — | — | EP | disclosed |
| EP-2468719-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2013-10-16 | — | — | EP | disclosed |
| EP-2137144-B1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | UBE INDUSTRIES (JP) | 2013-07-31 | — | — | EP | disclosed |
| US-8399720-B2 | Methods for producing fluorinated phenylsulfur pentafluorides | UBE INDUSTRIES, LTD. (JP) | 2013-03-19 | — | — | US | disclosed |
| EP-2468719-A1 | Process for producing arylsulfur pentafluorides | UBE Industries, Ltd. (JP) | 2012-06-27 | — | — | EP | disclosed |
| EP-2468721-A1 | Process for producing arylsulfur pentafluorides | UBE Industries, Ltd. (JP) | 2012-06-27 | — | — | EP | disclosed |
| US-20100029992-A1 | Process for Producing Arylsulfur Pentafluorides | IM&T RESEARCH, INC. (US) | 2010-02-04 | — | — | US | disclosed |
| EP-2137144-A1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | IM&T Research, Inc. (US) | 2009-12-30 | — | — | EP | disclosed |
| US-20090287024-A1 | Process for Producing Arylsulfur Pentafluorides | IM&T RESEARCH, INC. (US) | 2009-11-19 | — | — | US | disclosed |
| EP-1768667-B1 | CANNABINOID RECEPTOR LIGANDS | SCHERING CORP (US) | 2009-09-30 | — | — | EP | disclosed |
| US-7592491-B2 | Process for producing arylsulfur pentafluorides | IM&T RESEARCH, INC. (US) | 2009-09-22 | — | — | US | disclosed |
| WO-2008118787-A1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | IM & T RESEARCH, INC. (US) | 2008-10-02 | — | — | WO | disclosed |
| US-20080234520-A1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | IM&T RESEARCH, INC. (US) | 2008-09-25 | — | — | US | disclosed |
| EP-1768667-A1 | CANNABINOID RECEPTOR LIGANDS | SCHERING CORPORATION (US) | 2007-04-04 | — | — | EP | disclosed |
| US-20060100228-A1 | Cannabinoid receptor ligands | SCHERING CORPORATION | 2006-05-11 | — | — | US | disclosed |
| WO-2006002133-A1 | CANNABINOID RECEPTOR LIGANDS | SCHERING CORPORATION (US) | 2006-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060100228-A1 | Cannabinoid receptor ligands | CNR1, CNR2, TRPV1 | EPHX2 1571/4885MAPT 2622/4885GPR3 8/4885 |
| US-20090287024-A1 | Process for Producing Arylsulfur Pentafluorides | PFAS, MPST, ARSA | EPHX2 1946/4885MAPT 3764/4885GPR3 3475/4885 |
| US-20080234520-A1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | PFAS, MPST, ARSA | EPHX2 1946/4885MAPT 3764/4885GPR3 3475/4885 |
| US-20100029992-A1 | Process for Producing Arylsulfur Pentafluorides | PFAS, MPST, ARSA | EPHX2 1946/4885MAPT 3764/4885GPR3 3475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.